EUVIMEDEUVIMED entdecken
Crossref

Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking

Guibin Weng, Weimin Fang, Weikun Su, Lin Chen, Menglin Liao, Yijin Lin

Indian Journal of Pharmaceutical Education and Research · 23.04.2026 · 60 (3) · 1268-1275

DOI: 10.5530/ijper.20260503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 23.04.2026. Verfasst von Guibin Weng und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Weng, G., Fang, W., Su, W., Chen, L., Liao, M., & Lin, Y. (2026). Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking. Indian Journal of Pharmaceutical Education and Research, 60(3), 1268-1275. https://doi.org/10.5530/ijper.20260503

Vancouver

Weng G, Fang W, Su W, Chen L, Liao M, Lin Y. Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking. Indian Journal of Pharmaceutical Education and Research. 2026;60(3):1268-1275. doi:10.5530/ijper.20260503

BibTeX
@article{Weng2026,
  author = {Weng, Guibin and Fang, Weimin and Su, Weikun and Chen, Lin and Liao, Menglin and Lin, Yijin},
  title = {Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking},
  journal = {Indian Journal of Pharmaceutical Education and Research},
  year = {2026},
  volume = {60},
  number = {3},
  pages = {1268--1275},
  doi = {10.5530/ijper.20260503}
}
Kostenlos starten →